Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-52,641
Closed -$5.02M 260
2019
Q1
$5.02M Buy
+52,641
New +$6.57M 0.2% 115
2015
Q4
Sell
-133,997
Closed -$6.51M 328
2015
Q3
$6.51M Sell
133,997
-122,073
-48% -$5.8M 0.34% 105
2015
Q2
$11.4M Sell
256,070
-16,873
-6% -$647K 0.54% 62
2015
Q1
$10.3M Sell
272,943
-89,085
-25% -$2.88M 0.52% 65
2014
Q4
$11.4M Buy
362,028
+89,818
+33% +$2.18M 0.6% 53
2014
Q3
$5.61M Buy
272,210
+3,240
+1% +$65.8K 0.33% 100
2014
Q2
$6.07M Buy
268,970
+117,690
+78% +$1.95M 0.34% 100
2014
Q1
$2.5M Buy
+151,280
New +$2.69M 0.14% 178

Other funds holding INGN

Emerald Advisers's INGN Position: Q2 2019 in Review

Emerald Advisers sold out of Inogen (INGN) in Q2 2019, closing a stake of 52,641 shares — an estimated $5.02M sold.

Emerald Advisers first reported a position in INGN in Q1 2014 and held it in 8 quarters. The position peaked at $11.4M in Q2 2015. 197 funds tracked by Wall St. Rank hold INGN as of Q2 2019.

  • Emerald Advisers reported no remaining Inogen position as of Q2 2019 after selling out during the quarter.
  • Emerald Advisers sold 52,641 Inogen shares in Q2 2019, an estimated $5.02M.
  • Emerald Advisers first reported a position in Inogen in Q1 2014 and held it in 8 quarters.
  • Emerald Advisers's Inogen position peaked at $11.4M in Q2 2015.
  • 197 funds tracked by Wall St. Rank held Inogen as of Q2 2019.

Based on Emerald Advisers's 13F filing for Q2 2019, filed 31 Jul 2019.